Open Letter to AstraZeneca
Urgent Appeal for the Introduction of Symbicort Turbuhaler DPI to the U.S.
We, as health and sustainability professionals and organizations concerned about the impact of the accelerating climate crisis on public health, are writing to AstraZeneca with a plea to make their Symbicort Turbuhaler dry powder inhaler (DPI) available in the United States as soon as possible.
You can read the full letter here: https://docs.google.com/document/d/1pINoQVM-i7U-1EiH-wI__zTwAX2_ktXiO35hIsnKEWU/edit?usp=sharing
Sign in to Google to save your progress. Learn more
Email *
Name & any academic degrees (e.g. John Smith, MD, MPH) *
Title *
Affiliation *
Name of affiliated institution or organization (If none, please write "N/A"). *
Do you have the authority to sign on for your organization or institution? (If not we will sign you on as an individual.) *
This petition was organized by Greater Boston Physicians for Social Responsibility. Visit our website to connect with or find out more about us: GBPSR.org
Submit
Clear form
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. - Terms of Service - Privacy Policy

Does this form look suspicious? Report

Google Forms